Skip to content

Clinical trials

Phase 2 Non-alcoholic Fatty Liver Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 2 Country / region: United States Clear all

191 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20033
20051
20064
20073
20083
20102
20113
20124
20136
20147
201515
201614
201712
201811
201926
202018
202119
20229
202314
20248
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Terminated31
Recruiting14
Active, not recruiting7
Unknown status6
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12
Gilead Sciences11
Novartis Pharmaceuticals7
Pfizer6
University of California, San Diego6
Zydus Therapeutics Inc.6
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC5
GlaxoSmithKline4
University of Michigan4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease191
Fatty Liver32
Liver Cirrhosis19
Diabetes Mellitus, Type 218
Fibrosis17
Liver Diseases17
Obesity13
Diabetes Mellitus10
Insulin Resistance7
Digestive System Diseases6

Trials

Showing 1 to 25 of 191. Each trial links to its page on Pharma Observatory.

91 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.